(Q44525682)

3 December 2017

0 references

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. (English)

1 reference

3 December 2017

1 reference

Berthold F

1

1 reference

3 December 2017

Hero B

2

1 reference

3 December 2017

Kremens B

3

1 reference

3 December 2017

Handgretinger R

4

1 reference

3 December 2017

Henze G

5

1 reference

3 December 2017

Schilling FH

6

1 reference

3 December 2017

Schrappe M

7

1 reference

3 December 2017

Simon T

8

1 reference

3 December 2017

Spix C

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

197

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

11-17

1 reference

Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experience

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Neuroblastoma Screening at One Year of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900076-4

7 January 2021

10.1016/S0304-3835(03)00076-4

Identifiers

DOI

1 reference

3 December 2017

1 reference